Mandag var der fokus på ALK, ChemoMetec og GN Store Nord. ALK meddelte lørdag, at de har købt rettighederne til næsesprayen Neffy. Aftalen er indgået med det amerikanske selskab ARS Pharmaceuticals og omfatter rettighederne til næsesprayen Neffy mod allergiske chok. Aktien steg med mere end 7 pct. På ugebasis er der salgssignal i Bollingerkanalen, mens… Læs mere Er der et jule-rally på vej?
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Powered by 